陈砺, 朱春燕, 王小平, 徐敏. 绝经后骨质疏松症中药治疗研究文献的质量评价[J]. 循证医学, 2004, 4(3): 141-144. DOI: 10.3969/j.issn.1671-5144.2004.03.005
    引用本文: 陈砺, 朱春燕, 王小平, 徐敏. 绝经后骨质疏松症中药治疗研究文献的质量评价[J]. 循证医学, 2004, 4(3): 141-144. DOI: 10.3969/j.issn.1671-5144.2004.03.005
    Quality evaluation of clinical trial articles of postmenopausal osteoporosis treated with Chinese medicine[J]. Journal of Evidence-Based Medicine, 2004, 4(3): 141-144. DOI: 10.3969/j.issn.1671-5144.2004.03.005
    Citation: Quality evaluation of clinical trial articles of postmenopausal osteoporosis treated with Chinese medicine[J]. Journal of Evidence-Based Medicine, 2004, 4(3): 141-144. DOI: 10.3969/j.issn.1671-5144.2004.03.005

    绝经后骨质疏松症中药治疗研究文献的质量评价

    Quality evaluation of clinical trial articles of postmenopausal osteoporosis treated with Chinese medicine

    • 摘要: 目的了解目前国内中药治疗绝经后骨质疏松症的临床治疗研究的现状.方法对检索到的50篇有关中药治疗绝经后骨质疏松症的临床研究论文,按照牛津循证医学中心证据水平标准和临床试验的设计原则,从诊断标准、纳入和排除标准、组间基线可比性、随机、对照、双盲、统计学方法、疗效判断、疗程及药物的不良反应、随访等多个方面进行分析评价.结果50篇相关文献中,按照牛津循证医学中心证据水平标准评价,推荐级别为B级的占44.0%,C级的占56.0%;证据水平为2b级的占40.0%,3b级的占4.0%,4级的占56.0%;随机对照试验文

       

    /

    返回文章
    返回